Summary by Moomoo AI
Todd Franklin Watanabe, associated with Arcutis Biotherapeutics, completed a sale of 14,903 shares of common stock on March 4, 2024. The transaction was executed at a price of $11.1212 per share, resulting in a total sale value of approximately $165,739.24. Following the sale, Watanabe directly holds 874,533 shares of the company. Additionally, Watanabe has indirect ownership of 231,140 shares through trusts and an LLC. The sale was conducted in the open market.